NYSE Active Runners: AT&T (NYSE:T), General Electric Company (NYSE:GE), Corning Incorporated (NYSE:GLW), Pfizer Inc. (NYSE:PFE)

AT&T, Inc. (NYSE:T) has turned on the nation’s most reliable 4G LTE network** in Traverse City, bringing customers the latest generation of wireless network technology. Those who live and work in Grand Traverse and Leelanau counties, including along M-37, M-22, U.S. Highway 31 and County Highway 611 will be most affected by the increased speed. AT&T, Inc. (NYSE:T) stock performance was 0.75% in last session … Continue reading NYSE Active Runners: AT&T (NYSE:T), General Electric Company (NYSE:GE), Corning Incorporated (NYSE:GLW), Pfizer Inc. (NYSE:PFE)

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. Pfizer Inc. (NYSE:PFE) stock performance was 1.05% in last session and finished the day at $31.82. Traded volume was 21.09million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)

Atlantic Equities downgrades shares of Bank of America (NYSE:BAC) from Overweight to Neutral and lowered the price target from $20 to $18.50 Bank of America Corp (NYSE:BAC) stock performance was -1.08% in last session and finished the day at $17.37. Traded volume was 118,100,416 million shares in the last session and the average volume of the stock remained 109.13 million shares. The beta of the … Continue reading NYSE most active: Bank of America (NYSE:BAC), Pfizer Inc. (NYSE:PFE), Verizon Communications (NYSE:VZ), Petroleo Brasileiro Petrobras (NYSE:PBR)

US pharma giant Pfizer (NYSE:PFE) has announced detailed results from OPT Compare (A3921080), a Phase III study of tofacitinib (trade name Xeljanz), the first in a new class of treatment, oral Janus kinase (JAK) inhibitors, the safety and efficacy of which are being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis. Pfizer Inc. (NYSE:PFE) stock performance was -2.14% in last session and … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), Merck & Co (NYSE:MRK)

Trading in Pfizer Inc. (NYSE:PFE) was halted last week because of pending news. While we see that all the time in smaller biotechs, MannKind will likely be halted next week during an FDA advisory committee meeting. Pfizer Inc. (NYSE:PFE) stock performance was 0.85% in last session and finished the day at $32.18. Traded volume was 62.72million shares in the last session and the average volume … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

Arena Pharmaceuticals Inc (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) in early 2012 as each company headed into their regulatory reviews with the U.S. Food and Drug Administration, or FDA, for their respective obesity medications. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -2.84% in last session and finished the day at $6.49. Traded volume was 6.83million shares in the last session and the average … Continue reading Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)